$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

$aawh Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000162828022014103 Filed on May 12, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$85.09M	$66.14M
YoY Change	28.66%	192.75%
Cost Of Revenue	$61.64M	$36.47M
YoY Change	69.02%	141.52%
Gross Profit	$23.45M	$29.67M
YoY Change	-20.97%	295.98%
Gross Profit Margin	27.56%	44.86%
Selling, General & Admin	$33.90M	$25.68M
YoY Change	32.02%	155.52%
% of Gross Profit	144.59%	86.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.918M	$6.254M
YoY Change	58.59%	70.87%
% of Gross Profit	42.3%	21.08%
Operating Expenses	$38.23M	$61.66M
YoY Change	-38.0%	539.0%
Operating Profit	-$14.78M	-$31.99M
YoY Change	-53.8%	1383.08%
Interest Expense	$6.031M	$7.337M
YoY Change	-17.8%	190.0%
% of Operating Profit
Other Income/Expense, Net	-$5.928M	-$7.257M
YoY Change	-18.31%	187.52%
Pretax Income	-$20.71M	-$39.25M
YoY Change	-47.24%	738.43%
Income Tax	$7.107M	$8.976M
% Of Pretax Income
Net Earnings	-$27.82M	-$48.22M
YoY Change	-42.32%	544.86%
Net Earnings / Revenue	-32.69%	-72.91%
Basic Earnings Per Share	-$0.16	-$0.45
Diluted Earnings Per Share	-$0.16	-$0.45
COMMON SHARES
Basic Shares Outstanding	172.5M shares	106.4M shares
Diluted Shares Outstanding	172.5M shares	106.4M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.8M	$62.63M
YoY Change	129.59%
Cash & Equivalents	$143.8M	$62.63M
Short-Term Investments
Other Short-Term Assets	$22.65M	$23.19M
YoY Change	-2.32%
Inventory	$78.23M	$38.62M
Prepaid Expenses	$6.616M	$2.304M
Receivables	$10.37M	$7.115M
Other Receivables	$5.500M	$8.867M
Total Short-Term Assets	$260.6M	$141.1M
YoY Change	84.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$226.1M	$150.1M
YoY Change	50.68%
Goodwill	$43.02M	$24.30M
YoY Change	77.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.93M	$19.65M
YoY Change	1.41%
Total Long-Term Assets	$453.7M	$340.2M
YoY Change	33.34%
TOTAL ASSETS
Total Short-Term Assets	$260.6M	$141.1M
Total Long-Term Assets	$453.7M	$340.2M
Total Assets	$714.2M	$481.3M
YoY Change	48.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.04M	$21.34M
YoY Change	-15.46%
Accrued Expenses	$10.21M	$13.64M
YoY Change	-25.15%
Deferred Revenue	$460.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$11.11M	$47.67M
YoY Change	-76.7%
Total Short-Term Liabilities	$109.3M	$126.1M
YoY Change	-13.32%
LONG-TERM LIABILITIES
Long-Term Debt	$222.6M	$201.6M
YoY Change	10.44%
Other Long-Term Liabilities	$224.3M	$168.1M
YoY Change	33.39%
Total Long-Term Liabilities	$222.6M	$201.6M
YoY Change	10.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$109.3M	$126.1M
Total Long-Term Liabilities	$222.6M	$201.6M
Total Liabilities	$556.2M	$495.8M
YoY Change	12.18%
SHAREHOLDERS EQUITY
Retained Earnings	-$214.1M	-$111.8M
YoY Change	91.44%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$158.0M	-$14.52M
YoY Change
Total Liabilities & Shareholders Equity	$714.2M	$481.3M
YoY Change	48.39%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$27.82M	-$48.22M
YoY Change	-42.32%	544.86%
Depreciation, Depletion And Amortization	$9.918M	$6.254M
YoY Change	58.59%	70.87%
Cash From Operating Activities	-$10.25M	-$7.829M
YoY Change	30.86%	-302.77%
INVESTING ACTIVITIES
Capital Expenditures	$10.21M	$23.35M
YoY Change	-56.26%	208.83%
Acquisitions	$24.89M	$11.17M
YoY Change	122.75%
Other Investing Activities	$9.592M	-$11.85M
YoY Change	-180.93%
Cash From Investing Activities	-$622.0K	-$35.20M
YoY Change	-98.23%	354.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$786.0K	$1.286M
YoY Change	-38.88%
Cash From Financing Activities	-$817.0K	$48.21M
YoY Change	-101.69%	1171.13%
NET CHANGE
Cash From Operating Activities	-$10.25M	-$7.829M
Cash From Investing Activities	-$622.0K	-$35.20M
Cash From Financing Activities	-$817.0K	$48.21M
Net Change In Cash	-$11.68M	$5.182M
YoY Change	-325.47%	-5732.61%
FREE CASH FLOW
Cash From Operating Activities	-$10.25M	-$7.829M
Capital Expenditures	$10.21M	$23.35M
Free Cash Flow	-$20.46M	-$31.18M
YoY Change	-34.38%	742.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001756390
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	333-254800
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ASCEND WELLNESS HOLDINGS, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0602006
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1411 Broadway
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	16th Floor
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10018
CY2022Q1	dei	City Area Code CityAreaCode	646
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	661-7600
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	143797000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	155481000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10371000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7612000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	78233000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	65588000	USD
CY2022Q1	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5500000	USD
CY2021Q4	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	4500000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22651000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24831000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	260552000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	258012000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	226129000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239656000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	107279000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103958000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	57301000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59271000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	43018000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	42967000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19925000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19572000	USD
CY2022Q1	us-gaap	Assets Assets	714204000	USD
CY2021Q4	us-gaap	Assets Assets	723436000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	46771000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45454000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	11107000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27940000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3606000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2665000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	43791000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	36184000	USD
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4053000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5152000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	109328000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	117395000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	222593000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230846000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	223981000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	197295000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	276000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1423000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	556178000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	546959000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	371916000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	362555000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-214064000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186249000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	158026000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	176477000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	714204000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	723436000	USD
CY2022Q1	us-gaap	Revenues Revenues	85090000	USD
CY2021Q1	us-gaap	Revenues Revenues	66137000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	61643000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	36470000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	23447000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	29667000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33227000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25146000	USD
CY2022Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	5000000	USD
CY2021Q1	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	36511000	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	38227000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	61657000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14780000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-31990000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	6031000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	7337000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	103000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	80000	USD
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5928000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7257000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20708000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39247000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7107000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8976000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-27815000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	172494000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172494000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	172494000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106443000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	106443000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	106443000	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	176477000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14306000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4942000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-27815000	USD
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	158026000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3786000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2487000	USD
CY2021Q1	aawh	Stock Issued During Period Value Litigation Settlement StockIssuedDuringPeriodValueLitigationSettlement	27431000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-14519000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-27815000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-48223000	USD
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9918000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6254000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	291000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	352000	USD
CY2022Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	571000	USD
CY2021Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	3255000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5715000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2487000	USD
CY2022Q1	aawh	Equity Issued In Litigation Settlement EquityIssuedInLitigationSettlement	0	USD
CY2021Q1	aawh	Equity Issued In Litigation Settlement EquityIssuedInLitigationSettlement	27431000	USD
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1147000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-796000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-818000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2759000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	888000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15217000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11320000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-3031000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	563000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	353000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6914000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9950000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	16903000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1099000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-446000	USD
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	244000	USD
CY2021Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	414000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	7607000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Taxes Payable IncreaseDecreaseInAccruedTaxesPayable	4225000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10245000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7829000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10214000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23351000	USD
CY2022Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	1000000	USD
CY2021Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	760000	USD
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	82000	USD
CY2021Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	82000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	35400000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	USD
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	24890000	USD
CY2021Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	11174000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-622000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35203000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	49500000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	786000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1286000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	31000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-817000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48214000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11684000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5182000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	155481000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	58097000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	143797000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	63279000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	5133000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	3426000	USD
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	650000	USD
CY2021Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	5562000	USD
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10695000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10583000	USD
CY2022Q1	aawh	Tax Withholding Share Based Payment Arrangement Incurred But Not Yet Paid TaxWithholdingShareBasedPaymentArrangementIncurredButNotYetPaid	4942000	USD
CY2021Q1	aawh	Tax Withholding Share Based Payment Arrangement Incurred But Not Yet Paid TaxWithholdingShareBasedPaymentArrangementIncurredButNotYetPaid	0	USD
CY2022Q1	us-gaap	Nature Of Operations NatureOfOperations	THE COMPANY AND NATURE OF OPERATIONS<div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ascend Wellness Holdings, Inc., which operates through its subsidiaries (collectively referred to as “AWH,” “Ascend,” “we,” “us,” “our,” or the “Company”), is a multi-state operator in the United States cannabis industry. AWH owns, manages, and operates cannabis cultivation facilities and dispensaries in several states across the United States, including Illinois, Michigan, Ohio, Massachusetts, New Jersey, and Pennsylvania. AWH is headquartered in New York, New York.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company was originally formed on May 15, 2018 as Ascend Group Partners, LLC, and changed its name to “Ascend Wellness Holdings, LLC” on September 10, 2018. On April 22, 2021, Ascend Wellness Holdings, LLC converted into a Delaware corporation and changed its name to “Ascend Wellness Holdings, Inc.” and effected a 2-for-1 reverse stock split (the “Reverse Split”), which is retrospectively presented for all periods in these financial statements. We refer to this conversion throughout this filing as the “Conversion.” As a result of the Conversion, the members of Ascend Wellness Holdings, LLC became holders of shares of stock of Ascend Wellness Holdings, Inc. The historical consolidated financial statements prior to the Conversion date are those of Ascend Wellness Holdings, LLC and its subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Conversion, the Company has authorized 750,000 shares of Class A common stock with a par value of $0.001 per share, 100 shares of Class B common stock with a par value of $0.001 per share and 10,000 shares of preferred stock with a par value of $0.001 per share. The rights of the holders of Class A common stock and Class B common stock are identical, except for voting and conversion rights. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 1,000 votes per share and is convertible at any time into one share of Class A common stock at the option of the holder. On May 4, 2021, the Company completed an Initial Public Offering (“IPO”) of its Class A common stock. See Note 12, “Stockholders’ Equity,” for additional details.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of the Company’s Class A common stock are listed on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “AAWH.U” and are quoted on the OTCQX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span> Best Market (the “OTCQX”) under the symbol “AAWH.” We are an emerging growth company under federal securities laws and as such we are able to elect to follow scaled disclosure requirements for this filing.
CY2021Q2	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts. We base our estimates on historical experience, known or expected trends, independent valuations, and various other measurements that we believe to be reasonable under the circumstances. As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.</span></div>
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11447000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	47187000	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q1	us-gaap	Revenues Revenues	85090000	USD
CY2021Q1	us-gaap	Revenues Revenues	66137000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	460000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	518000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	625000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	374000	USD
CY2022Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	14488000	USD
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	8899000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	38874000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	28235000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	24871000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	28454000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	78233000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	65588000	USD
CY2022Q1	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	13134000	USD
CY2021Q1	aawh	Compensation Costs Capitalized During The Period CompensationCostsCapitalizedDuringThePeriod	6363000	USD
CY2022Q1	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	12723000	USD
CY2021Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	8571000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	5500000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	4500000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	252451000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	260985000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26322000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21329000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	226129000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	239656000	USD
CY2022Q1	us-gaap	Depreciation Depreciation	5378000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	2951000	USD
CY2022Q1	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	4208000	USD
CY2021Q4	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	4393000	USD
CY2021Q1	aawh	Inventory Depreciation Capitalized During The Period InventoryDepreciationCapitalizedDuringThePeriod	1956000	USD
CY2022Q1	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	3541000	USD
CY2021Q4	aawh	Inventory Capitalized Depreciation InventoryCapitalizedDepreciation	2070000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-946000	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-946000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	385000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	385000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75624000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	75624000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	18323000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	16353000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	5774000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	57301000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59271000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1970000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1685000	USD
CY2022Q1	aawh	Inventory Amortization Capitalized During The Period InventoryAmortizationCapitalizedDuringThePeriod	408000	USD
CY2021Q1	aawh	Inventory Amortization Capitalized During The Period InventoryAmortizationCapitalizedDuringThePeriod	261000	USD
CY2022Q1	aawh	Inventory Capitalized Amortization InventoryCapitalizedAmortization	702000	USD
CY2021Q4	aawh	Inventory Capitalized Amortization InventoryCapitalizedAmortization	502000	USD
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	42967000	USD
CY2022Q1	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	51000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	43018000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	107279000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	103958000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3606000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2665000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	223981000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	197295000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	227587000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	199960000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	7390000	USD
CY2022Q1	aawh	Inventory Lease Costs Capitalized InventoryLeaseCostsCapitalized	6699000	USD
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	128000	USD
CY2022Q1	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	128000	USD
CY2022Q1	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	1206000	USD
CY2021Q1	aawh	Short Term Lease And Variable Lease Cost ShortTermLeaseAndVariableLeaseCost	652000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	6829000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	5069000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30746000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	11442000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P16Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y9M18D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.148
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.127
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	24060000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	33028000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	33952000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	34903000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	35488000	USD
CY2022Q1	aawh	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	472009000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	633440000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	405853000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	227587000	USD
CY2021Q2	aawh	Sale Leaseback Transaction Expected Purchase Price SaleLeasebackTransactionExpectedPurchasePrice	350000	USD
CY2022Q1	aawh	Financing Liability To Be Paid Remainder Of Fiscal Year FinancingLiabilityToBePaidRemainderOfFiscalYear	1567000	USD
CY2022Q1	aawh	Financing Liability To Be Paid Year One FinancingLiabilityToBePaidYearOne	2143000	USD
CY2022Q1	aawh	Financing Liability To Be Paid Year Two FinancingLiabilityToBePaidYearTwo	2206000	USD
CY2022Q1	aawh	Financing Liability To Be Paid Year Three FinancingLiabilityToBePaidYearThree	2271000	USD
CY2022Q1	aawh	Financing Liability To Be Paid Year Four FinancingLiabilityToBePaidYearFour	2338000	USD
CY2022Q1	aawh	Financing Liability To Be Paid After Year Four FinancingLiabilityToBePaidAfterYearFour	6811000	USD
CY2022Q1	aawh	Financing Liability FinancingLiability	17336000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	241243000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	266866000	USD
CY2022Q1	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	11140000	USD
CY2021Q4	aawh	Long Term Debt Current Maturities Gross LongTermDebtCurrentMaturitiesGross	27980000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	33000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	40000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	11107000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	27940000	USD
CY2022Q1	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	230103000	USD
CY2021Q4	aawh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	238886000	USD
CY2022Q1	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	7510000	USD
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	8040000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	222593000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	230846000	USD
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	4943000	USD
CY2021Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3426000	USD
CY2022Q1	aawh	Amortization Of Debt Discount And Non Cash Interest Expense AmortizationOfDebtDiscountAndNonCashInterestExpense	573000	USD
CY2021Q1	aawh	Amortization Of Debt Discount And Non Cash Interest Expense AmortizationOfDebtDiscountAndNonCashInterestExpense	3412000	USD
CY2022Q1	aawh	Interest On Financing Liability InterestOnFinancingLiability	515000	USD
CY2021Q1	aawh	Interest On Financing Liability InterestOnFinancingLiability	499000	USD
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6031000	USD
CY2021Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7337000	USD
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0
CY2021Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q2	aawh	Restricted Stock No Par Value RestrictedStockNoParValue	0
CY2022Q1	us-gaap	Shares Outstanding SharesOutstanding	174457000	shares
CY2021Q4	us-gaap	Shares Outstanding SharesOutstanding	171586000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3531000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2021	aawh	Class Of Warrant Or Right Weighted Average Remaining Exercise Period ClassOfWarrantOrRightWeightedAverageRemainingExercisePeriod	P2Y
CY2021Q4	aawh	Class Of Warrant Or Right Intrinsic Value Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightIntrinsicValueExercisePriceOfWarrantsOrRights	9216000	USD
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3531000	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.00
CY2022Q1	aawh	Class Of Warrant Or Right Weighted Average Remaining Exercise Period ClassOfWarrantOrRightWeightedAverageRemainingExercisePeriod	P1Y9M18D
CY2022Q1	aawh	Class Of Warrant Or Right Intrinsic Value Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightIntrinsicValueExercisePriceOfWarrantsOrRights	71000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1331000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.10
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1331000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.10
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	0	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.10
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2590000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y6M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y9M
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.700
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.97
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5715000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2487000	USD
CY2022Q1	aawh	Share Based Payment Arrangement Expense Capitalized During The Period ShareBasedPaymentArrangementExpenseCapitalizedDuringThePeriod	3211000	USD
CY2022Q1	aawh	Inventory Capitalized Equity Compensation Cost InventoryCapitalizedEquityCompensationCost	4030000	USD
CY2021Q4	aawh	Inventory Capitalized Equity Compensation Cost InventoryCapitalizedEquityCompensationCost	4814000	USD
CY2021Q1	aawh	Share Based Payment Arrangement Expense Capitalized During The Period ShareBasedPaymentArrangementExpenseCapitalizedDuringThePeriod	0	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20708000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39247000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7107000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8976000	USD
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.343
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.229
CY2022Q1	us-gaap	Gross Profit GrossProfit	23447000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	29667000	USD
CY2022Q1	aawh	Effective Income Tax Rate As A Percentage Of Gross Profit EffectiveIncomeTaxRateAsAPercentageOfGrossProfit	0.303
CY2021Q1	aawh	Effective Income Tax Rate As A Percentage Of Gross Profit EffectiveIncomeTaxRateAsAPercentageOfGrossProfit	0.303
CY2021Q4	aawh	Supply Agreement Percentage Of Gross Monthly Sales For Initial Term SupplyAgreementPercentageOfGrossMonthlySalesForInitialTerm	0.075
CY2021Q4	aawh	Supply Agreement Initial Term SupplyAgreementInitialTerm	P5Y
CY2021Q4	aawh	Supply Agreement Percentage Of Gross Monthly Sales After Initial Term SupplyAgreementPercentageOfGrossMonthlySalesAfterInitialTerm	0.05
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6616000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7508000	USD
CY2022Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4741000	USD
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	5177000	USD
CY2022Q1	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	3439000	USD
CY2021Q4	aawh	Tenant Improvement Allowance Current TenantImprovementAllowanceCurrent	2507000	USD
CY2022Q1	aawh	Construction Deposits Current ConstructionDepositsCurrent	2132000	USD
CY2021Q4	aawh	Construction Deposits Current ConstructionDepositsCurrent	3263000	USD
CY2022Q1	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	5723000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	6376000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	22651000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	24831000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18041000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5536000	USD
CY2022Q1	aawh	Accrued Capital Expenditures AccruedCapitalExpenditures	10695000	USD
CY2021Q4	aawh	Accrued Capital Expenditures AccruedCapitalExpenditures	15682000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6604000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11760000	USD
CY2022Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	5000000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	5480000	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6431000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6809000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	187000	USD
CY2022Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	46771000	USD
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	45454000	USD
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	14500000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10052000	USD
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	5986000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	5433000	USD
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	5864000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	3917000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2732000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2419000	USD
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	1339000	USD
CY2021Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	861000	USD
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	675000	USD
CY2021Q1	us-gaap	Marketing Expense MarketingExpense	534000	USD
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-818000	USD
CY2021Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	USD
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	1313000	USD
CY2021Q1	us-gaap	Other General Expense OtherGeneralExpense	1930000	USD
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33227000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25146000	USD

Files In Submission

Name	View Source	Status
0001628280-22-014103-index-headers.html	Edgar Link	pending
0001628280-22-014103-index.html	Edgar Link	pending
0001628280-22-014103.txt	Edgar Link	pending
0001628280-22-014103-xbrl.zip	Edgar Link	pending
aawh-20220331.htm	Edgar Link	pending
aawh-20220331.xsd	Edgar Link	pending
aawh-20220331_cal.xml	Edgar Link	unprocessable
aawh-20220331_def.xml	Edgar Link	unprocessable
aawh-20220331_g1.jpg	Edgar Link	pending
aawh-20220331_htm.xml	Edgar Link	completed
aawh-20220331_lab.xml	Edgar Link	unprocessable
aawh-20220331_pre.xml	Edgar Link	unprocessable
exhibit101-03312022.htm	Edgar Link	pending
exhibit102-03312022.htm	Edgar Link	pending
exhibit311-03312022.htm	Edgar Link	pending
exhibit312-03312022.htm	Edgar Link	pending
exhibit32-03312022.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh

2022 Q1 Form 10-Q Financial Statement

#000162828022014103 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH Ascend Wellness Holdings, Inc. Stock $aawh

2022 Q1 Form 10-Q Financial Statement

#000162828022014103 Filed on May 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AAWH
Ascend Wellness Holdings, Inc. Stock $aawh